Uncategorized – Page 2 – Svenningsson lab

29 September 2023

Visit and talk from Professor Michael Kaplitt

21 September 2023

New publication in Nature Communications

See PhD student Yachao He’s first author paper about prosaposin and Parkinson’s here

1 July 2023

Lab day 2023

2 April 20232 April 2023

31.03.23 – Per inaugurated as a member of the Royal Swedish Academy of Sciences

20 March 202320 March 2023

March 2023 – Neurolixis Announces Positive Ph2A Proof-of Concept on NLX-112 in Levodopa-Induced Dyskinesia in Parkinson’s Disease

A Phase IIA clinical trial for treating LID using a novel small molecule performed in collaboration with our clinical team has yielded positive results. Click below to download the full press release.

EINPresswire Download

7 March 2023

March 2023 – Meeting in Florida

Dinner party hosted by Göran Ennerfelt and Antonia Axson Johnson at Palm Beach in concordance with First Harvard-KI meeting supported by Nordstjernan/Lexa International

7 March 2023

17.02.2022 Public defense of Yachao He

Per and Xiaoqun together with Yachao at the thesis nailing

Per along with thesis opponent Miquel Vila, committee members Sophia Schedin Weiss and Anna Erlandsson, Xiaoqun and Yachao after the defense proceedings

Yachao giving a speech at the post-defense dinner

8 February 20238 February 2023

Visit from Bioarctic team

Lars Lannfelt and the team from Bioarctic (including lab alumni Ebba) visiting the lab to discuss future potential collaborations.

6 December 2022

New grant from Vetenskapsrådet

Funding of 19.96M SEK to conduct an RCT of Montelukast for treating Parkinson’s disease has been awarded to the group. Link for more information can be found here.

19 September 2022

Per Svenningsson elected into the Royal Swedish Academy of Sciences

Link to the news article can be found here